Lotus Neuro Appoints Junghae Suh PhD as Chief Technology Officer

Lotus Neuro, a clinical-stage neuro-therapeutics company combining precision focused ultrasound (FUS) with advanced medicines to treat brain disease, today announced the appointment of Junghae Suh PhD as Chief Technology Officer. Dr. Suh will lead the continued development of the company's programmable delivery platform, advancing the technology that enables measurable, controllable therapeutic effects across the blood-brain barrier.

lotusneuro.com/...